Literature DB >> 18508370

Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation.

Olivier Scatton1, Stéphane Zalinski, Benoit Terris, Jérémie H Lefevre, Alessandra Casali, Pierre-Philippe Massault, Filomena Conti, Yvon Calmus, Olivier Soubrane.   

Abstract

The objective of this study was to evaluate the histological profile obtained from primary resection of hepatocellular carcinoma (HCC) as a selection tool for liver transplantation (LT). The natural history of HCC depends on its histological features. The clinical effectiveness of resection as a selection tool for salvage or de principe LT has been previously advocated. Between 1987 and 2006, 20 patients underwent a resection prior to LT. Long-term survival of these 20 patients was compared to that of 73 patients who underwent primary LT. Histological features of the resected specimen were compared to those of the recurrences. Feasibility, morbidity, and mortality of LT following primary resection were also analyzed. Mean follow-up was 3.8 +/- 4.4 and 2.7 +/- 4.5 years from resection and LT, respectively; 6 patients died. The mean 1-, 3-, 5-, and 10-year overall survival rates were 71%, 61%, 55%, and 45% and 74%, 66%, 66%, and 40% after primary transplantation and primary resection, respectively (not significant). At LT, 14 patients had a recurrence, but histological study of the recurrence was not possible in 2 (complete necrosis). For 9 patients (75%), histological features of both primary and recurrent tumors were exactly the same. Four patients had recurrence following LT; in each case, primary and recurrent nodules shared the same histological markers of poor prognosis. De principe transplantation was proposed to 6 patients because of poor prognosis histological features on the resected specimen. All these patients are alive without recurrence with a mean follow-up of 55 months. In conclusion, the natural history of HCC can be predicted on the basis of the histological profile of the resected specimen, which may be used as a selection tool for LT. De principe LT in patients within Milan criteria with poor prognosis histological features may be an optimal strategy.

Entities:  

Mesh:

Year:  2008        PMID: 18508370     DOI: 10.1002/lt.21431

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  24 in total

1.  Impact of preoperative α-fetoprotein level on disease-free survival after liver transplantation for hepatocellular carcinoma.

Authors:  Fabrice Muscari; Jean-Pascal Guinard; Nassim Kamar; Jean-Marie Peron; Philippe Otal; Bertrand Suc
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

Review 2.  Laparoscopic liver resections for hepatocellular carcinoma: current role and limitations.

Authors:  Martin Gaillard; Hadrien Tranchart; Ibrahim Dagher
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 3.  Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma.

Authors:  Bérénice Charrière; Charlotte Maulat; Bertrand Suc; Fabrice Muscari
Journal:  World J Hepatol       Date:  2016-07-28

4.  Surgical treatment for early hepatocellular carcinoma: comparison of resection and liver transplantation.

Authors:  Jian Zhou; Zheng Wang; Shuang-Jian Qiu; Xiao-Wu Huang; Jian Sun; Wen Gu; Jia Fan
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-11       Impact factor: 4.553

5.  Prognostic impact of underlying liver fibrosis and cirrhosis after curative resection of hepatocellular carcinoma.

Authors:  Peter Gassmann; Tilmann Spieker; Joerg Haier; Fabian Schmidt; Wolf Arif Mardin; Norbert Senninger
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

6.  Resection or Transplant in Early Hepatocellular Carcinoma.

Authors:  Markus B Schoenberg; Julian N Bucher; Adrian Vater; Alexandr V Bazhin; Jingcheng Hao; Markus O Guba; Martin K Angele; Jens Werner; Markus Rentsch
Journal:  Dtsch Arztebl Int       Date:  2017-08-07       Impact factor: 5.594

7.  Resection of a transplantable single-nodule hepatocellular carcinoma in Child-Pugh class A cirrhosis: factors affecting survival and recurrence.

Authors:  Fabrice Muscari; Bertrand Foppa; Nicolas Carrere; Nassim Kamar; Jean-Marie Peron; Bertrand Suc
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

Review 8.  Advances in managing hepatocellular carcinoma.

Authors:  Marielle Reataza; David K Imagawa
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

Review 9.  Hepatocellular carcinoma--resection or transplant?

Authors:  Sheung Tat Fan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-09-11       Impact factor: 46.802

10.  Laparoscopic resection of hepatocellular carcinoma: a French survey in 351 patients.

Authors:  Olivier Soubrane; Claire Goumard; Alexis Laurent; Hadrien Tranchart; Stéphanie Truant; Brice Gayet; Chadi Salloum; Guillaume Luc; Safi Dokmak; Tullio Piardi; Daniel Cherqui; Ibrahim Dagher; Emmanuel Boleslawski; Eric Vibert; Antonio Sa Cunha; Jacques Belghiti; Patrick Pessaux; Pierre-Yves Boelle; Olivier Scatton
Journal:  HPB (Oxford)       Date:  2013-07-24       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.